NanoViricides Inc. (NNVC)

[arvitar]

Here's to NNVC presenting another meeting abstract on cell culture studies before end of 2018!!!

What remarkably impressive progress beyond the nine animal studies and two clinical studies that were promised for 2014!!!

Solid steps forward!

August 2013: " The company currently has nine products in its pipeline currently undergoing animal testing, with its influenza drug FluCide and Dengue fever drug DengueCide approaching currently approaching human clinical trials.

“This is a unique technology and this far, we have gotten patents in 25 countries with 100 expected by the end of the year,” Seymour said. “Every single large pharma has expressed an interest in our technology but they all want to wait until we're in humans next year before proposing a licensing deal.”
www.biopharma-reporter.com/Upstream-Processing/NanoViricides-Builds-Plant-to-Prep-for-Viral-Penicillin-Pipeline